| > There are _plenty_ of people right here in the US who can't afford drugs because we insist that they should be 10x the price in the US than everywhere else. The very article explains this isn't true, as drug price doesn't really correlate with R&D costs. > There's also another negative side effect: due to what amounts to dumping, other countries essentially don't have any pharma research of their own That's wrong, too. According to [0], U.S. pharma companies globally spent about 70 billions, of which about 11 billions were spent in Western Europe, so net amount was at most (assuming nothing was spent outside the US and Western Europe) 59 billion dollars. By comparison, according to [1], R&D spend from national companies from Germany, Switzerland, UK and France were about 20 billion USD. So the population adjusted R&D spend relation is lower than 1:2 between Western Europe and the US. [0] = https://www.healthaffairs.org/do/10.1377/hblog20170307.05903... [1] = https://www.vfa.de/download/the-pharmaceutical-industry-in-g... |